Experts in food science, technology, and innovation gather to strengthen food security efforts TUMCREATE, the research facility of the Technical University of Munich (TUM) in Singapore, kicked off the second edition of its Proteins4Singapore (P4SG) research programme's TFOODS Conference, themed “Engaging with Alternative Proteins,” at Surbana Jurong Campus on 5th-6th November 2024. The Guest of Honour for TFOODS, Dr Amy Khor, Senior Minister of State for Sustainability and the … [Read more...] about TFOODS Conference 2024 sees global experts nurture Singapore’s ’30 by 30′ sustainable food vision
Asia Food Journal
Nourish Ingredients and CABIO Biotech announce strategic partnership to manufacture and distribute Tastilux®
Collaboration set to revolutionise the production and distribution of innovative food ingredients in China and globally SINGAPORE — 12 November 2024 — In a landmark cross-continental collaboration, Nourish Ingredients, a leader in speciality fats and precision fermentation, today announced a Joint Commercial Agreement with CABIO Biotech, a leading Chinese biotechnology company specialising in microbial fermentation and synthetic biology-based products. Uniting Australian innovation with … [Read more...] about Nourish Ingredients and CABIO Biotech announce strategic partnership to manufacture and distribute Tastilux®
Indorama Ventures reports improved 3Q24 earnings as the company’s IVL 2.0 strategy starts to deliver benefits while global demand continues to remain lacklustre
Indorama Ventures Public Company Limited (IVL), a global sustainable chemical producer, posted a marked improvement in quarterly performance as the chemical industry struggles to recover from a prolonged downturn and the company’s management executes their 3year IVL 2.0 strategy to enhance competitiveness and drive efficiencies. Indorama Ventures reported Adjusted EBITDA of $427 million in 3Q24, a gain of 32% YoY, supported by steady volumes, improving industry spreads, and the company’s … [Read more...] about Indorama Ventures reports improved 3Q24 earnings as the company’s IVL 2.0 strategy starts to deliver benefits while global demand continues to remain lacklustre
